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a b s t r a c t
Objective and importance: While bone invasion and hyperostosis are frequent phenomena in
meningiomas, primary intraosseous meningiomas are rare and their occurrence in the skull
base is an extraordinary exception. Moreover, radiation-induced meningiomas represent a
unique clinical dilemma given the fact that patients with these tumors had often received a
prior full course of radiotherapy.
Clinical presentation: A 42-year-old man presented with a 3-month history of progressively
worsening facial asymmetry. His medical history was consistent for a posterior cranial fossa
irradiation at the age of 6 years for a non-conﬁrmed brain stem tumor. On admission his
Karnofsky performance status was graded as 50% and his neurological examination showed
a complete right facial nerve paralysis and hearing impairment. Computed tomography and
magnetic resonance imaging demonstrated an osteolytic tumor invading the whole right
petrous bone without intracranial involvement.
Intervention: As the tumor reached the external auditory canal, a tissue sample was obtained
locally. Pathological examination of the lesion identiﬁed a grade II clear cell meningioma and
the patient was consequently addressed for an intensity modulated radiation therapy. His
condition remained unchanged till the most recent follow-up examination, 8 months later.
Conclusions: To the best of our knowledge, a radiation induced osteolytic clear cell meningio-
ma of the petrous bone has not been previously reported. As little literature exists regarding the
use of adjuvant therapies for these tumors, intensity modulated radiation therapy remains an
attractive treatment option in case of pervious irradiation and general status alteration.
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1. Introduction
Primary interosseous meningiomas are a subtype of primary
extradural meningiomas. With only 24 reported cases to date,
their osteolytic form is most uncommon.
To the best of our knowledge, a radiation induced osteolytic
clear cell meningioma of the petrous bone has not been
reported so far. The case presented highlights the possible
occurrence of a purely interosseous and aggressive meningio-
ma 36 years after conventional irradiation and searches the
relevant literature regarding the possible role of adjuvant
therapies in such exceptional situations.
2. Case report
This 43-year-old male was ﬁrst admitted to the neurosurgery
section in June 1979 with a progressively aggravating right
bulbar syndrome. A ventriculography by opaque injection was
ﬁrst realized and showed a moderate dilatation of the whole
ventricular system. Further investigation by a head computed
tomography showed a hypodensity in the right bulbar area
(Fig. 1). Although the imaging study was not afﬁrmative, the
patient was considered as having a brainstem tumor. Surgery
for such lesions was not feasible at that time and the decision
was to administer a full dose of radiation therapy without the
need of a pathological specimen. Consequently the patient
received 40 Gy over his posterior cranial fossa and was
discharged home few days later. His condition progressively
improved and he became symptom free within 4 months but
Fig. 1 – Head CT performed in June 1979 showing a right
bulbar hypodensity.
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In January 2015, he presented once again for a 1 month
history of heaviness, impaired hearing in the right ear, vertigo
and a progressively worsening right facial asymmetry.
On examination, his general status was altered with a
Karnofsky performance scale graded as 50%. His higher mental
functions were normal and his cranial nerves examination
was remarkable for a complete right facial nerve paralysisFig. 2 – Axial CT images of the petrous temporal bones demons
destruction of the mastoid process and lateral petrous region. T
involved.(House–Brackmann grade VI). Moreover, his Rinnie's test was
negative and Weber's test lateralized to the right side.
Hematological and biochemistry proﬁles were normal.
Contrast enhanced computed tomography of the head
(Brilliance 64-multislice CT scanner, Philips Medical System,
MA) revealed a heterogeneously enhancing osteolytic mass of
the right petrous bone. The tumor reached the right externaltrate a large lytic lesion on the right side with extensive
he external auditory meatus and middle ear cavity are also
Fig. 3 – Axial T1-weighted MRI with contrast enhancement
demonstrates a right-sided tumor of the petrous bone
without intracranial involvement.
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parenchyma seemed to be intact (Fig. 2).
Magnetic resonance imaging of the brain (Ingenia 3T MR
scanner, Philips Medical System, MA; with and without
contrast) showed a T1 isointense to hyper intense, T2 mixed
signal intensity, destructive lesion of the petrous bone
encompassing the ipsilateral facial nerve and internal carotid
artery without any intracranial extension (Fig. 3).
A gray-whitish tumor specimen was obtained from the
external auditory canal. On histopathological examination,
the tumor was composed of round to polygonal cells arranged
in whorls, showing clear cytoplasm and round to oval nuclei
with dispersed chromatin and inconspicuous nucleoli. There
was perivascular and interstitial deposition of a collagenous
material in a block manner. Tumor cells tested positive for PAS
and epithelial membrane antigen and the ﬁnal histological
diagnosis was a WHO grade II clear cell meningioma. Ki-67
labeling index was 7.5% (Fig. 4).Fig. 4 – Photomicrographs of the tumor specimens showing: (A) T
original magnification, T100.) (B) Diffuse membranous positivity
antigen, T40.)No surgical intervention was decided and we judged
preferable to address the patient directly to an intensity
modulated radiation therapy. His clinical status remained
unchanged till the most recent follow-up examination, 8
months later.
3. Discussion
Meningiomas are the most common benign intracranial
neoplasm and typically arise from meningocytes or ‘‘arach-
noid cap cells’’ located within the arachnoid layer of the
meninges. Meningiomas without contact with the surface of
the arachnoid membrane are labeled ‘‘ectopic meningiomas’’
[1,2] and were ﬁrst described by Winkler in 1904 [3]. While bone
invasion and hyperostosis are frequent phenomena in such
cases, primary intraosseous meningiomas without any addi-
tional soft tissue component are rare and almost all of them
are of osteoblastic subtype [4,5]. With only 24 reported cases to
date, the osteolytic subtype is most uncommon (Table 1) and
worth noted, only three localized in the skull base [1,11,18];
especially the petrous bone region.
This case is signiﬁcant not only because it satisﬁed the
criteria of a radiation-induced tumor deﬁned by Cahan in 1948
[25], making it the ﬁrst radiation induced meningioma of bone;
but also an intraosseous clear cell meningioma (CCM) has
never been previously reported.
CCM constitutes represents a rare variant of grade II
meningiomas accounting for only 0.2% of all meningiomas and
is distinct from more typical forms for being more locally
aggressive, associated to a recurrence rate as high as 61% and a
possible metastatic potential [26,27]. These tumors, moreover,
have no sex predilection and typically affect young individuals
in their mid to late twenties. They also differ from typical
forms in their site of occurrence. In fact, the majority of cases
of CCM were intradural spinal lesion (50%). Other possible sites
of occurrence include the supratentorium (21%), the cerebel-
lopontine angle (21%) and the foramen magnum and skull base
(7%) [26].
From a clinical standpoint, diagnosing an intraosseous
meningioma preoperatively is somehow difﬁcult to clinicians
even if the patient's symptoms include a gradually expanding
mass [5]. Imaging techniques are comparable to those used for
skull metastases, and appearance on MRI and CT is alsoumor cells having round nuclei with clear cytoplasm. (H&E,
 for epithelial membrane antigen. (Epithelial membrane
Table 1 – Literature review of intraosseous osteolytic
meningiomas.
Author, year Age Sex Location
Pearl et al., 1979 [6] 44 W Calvaria
Young, 1983 [7] n.p. n.p. Calvaria
Ammirati et al., 1990 [1] 21 M Skull base
Koga et al., 1993 [8] 63 M Calvaria
Ghobashy and Tobler, 1994 [9] 65 W Calvaria
Levin et al., 1995 [10] n.p. n.p. Calvaria
Ayadi et al., 1997 [11] 36 W Skull base
Changhong et al., 1997 [12] n.p. n.p. Calvaria
Muthukumar, 1997 [13] 55 M Calvaria
50 M Calvaria
65 M Calvaria
Lee et al., 1992 [14] 61 M Calvaria
Kaneko et al., 1988 [15] 71 W Calvaria
Qasho and Celli, 1998 [16] 46 W Calvaria
Okamoto et al., 2000 [17] 78 W Calvaria
Rosahl et al., 2004 [18] 38 M Skull base
Tokgoz et al., 2005 [19] 44 M Calvaria
Agrawal et al., 2007 [20] 70 W Calvaria
Sheikhrezaie et al., 2009 [21] 62 M Calvaria
Yener et al., 2009 [22] 78 M Calvaria
Kim et al., 2012 [5] 68 M Calvaria
74 W Calvaria
Bujok and Bienioszek, 2014 [23] 59 W Calvaria
Tang et al., 2014 [24] 82 W Calvaria
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 2 9 7 – 3 0 2300consistent. Osteolytic tumors of the skull base should include
chondroma, chondrosarcoma, dermoid, epidermoid tumor,
brown tumor, multiple myeloma, plasmacytoma, giant cell
tumor, aneurysmal bone cyst, eosinophilic granuloma, or
metastatic cancer [20,28]. But, regard of its distinct histological
features, clear cell meningioma needs to be differentiated from
other clear-cell neoplasms including metastatic renal-cell
carcinoma, pleomorphic xanthroastrocytoma, oligodendro-
glioma, hemangioblastoma, germinoma, lipid-rich glioblasto-
ma, and clear-cell ependymoma outlining the major role of
immunohistochemistry in assessing the differential diagnosis.
It has been already established that Meningiomas are the
most common radiation-induced neoplasms of the central
nervous system [29,30] and that the risk for development of
secondary meningiomas after high-dose cranial irradiation
increases with the duration of follow-up [29], reaching a
cumulative risk of 8.18% after 25 years [31]. Several authors
have also emphasized the relation between the tumor
histology and the latency period: a more pronounced
proliferative activity, results in a shorter latency and is
commonly associated with atypical/anaplastic variants [29].
But these reports are tempered by ones like ours in which a
locally aggressive tumor appeared almost 36 years after initial
irradiation.
Independently of the presumed radiation induced etiology
of our patient's tumor, understanding how a meningioma can
strictly develop in the intraosseous compartment is still
unclear and several explanations have been put forward to
explain the ectopic origin of primary intraosseous meningio-
mas: arachnoid cells may accompany cranial nerves during
their course through skull foramina [32] or localize in the
arterial sheath of vessels supplying the periosteum or piercing
the skull [3] and may develop into meningioma cells at a later
stage [33]. Alternatively, the mesenchymal origin of themeninges can explain the pathogenesis of primary intraoss-
eous meningiomas since multipotential mesenchymal cells
have the ability to differentiate into different tissue types,
particularly of meningeal subtype. Which is undoubtedly
supported by the fact that these tissues have been already
found as metaplasia in meningiomas [34]. In the present case,
an aggressive meningioma localized within the petrous bone.
In this location, we believe it reasonable to assume that
arachnoidal cell clusters found regularly at the level of the
internal auditory meatus, jugular foramen, at the geniculate
ganglion, the Eustachian tube or in association with the
greater and lesser superﬁcial petrosal nerves in autopsy
specimens of patients without meningioma [34], may probably
represent the cells of origin of this meningioma.
Even under the current therapeutic armamentarium,
intraosseous meningiomas still represent a real challenge
especially when located within the skull base. In addition, the
increasing number of survivals of patients with childhood
malignancies implies that the prevalence of radiation induced
intraosseous meningiomas is likely to increase in the future.
The mainstay of treatment remains complete surgical excision
since this has been shown to be associated with a better long-
term outcome compared with subtotal excision [35]; but an
extensive surgical excision is not always feasible like in our
case. Moreover, some patients already received the maximum
tolerable dose of radiation and conventional radiotherapy is
not an option: under these considerations, clinicians may
consider patients with such lesions as stronger candidates for
adjuvant therapies, depending on the clinical circumstances
[5] and the previous irradiation dose. Stereotactic radiosurgery
(SR) or fractionated stereotactic radiotherapy (FSR) may be
appropriate adjuncts to surgery or may be the alternative to
surgery in some high-risk patient independently of the
radiation-related relation of these tumors. The seize of the
tumor must also be considered in the management strategy
and facing a large tumor nearly invading the whole petrous
bone, IMRT can be of great help since it allows dose escalation.
Selected volumes can in fact be spared, but only at the expense
of higher dose to other areas.
Finally as current therapies are starting to integrate
molecular factors in the treatment of radiation induced
meningiomas, the role of medical therapies targeting aberrant
molecular pathways can be discussed. To date, several agents
such as hydroxyurea have been attempted with variable success
rates [36]. Interestingly, Bevacizumab, a monoclonal antibody
targeting VEGF, has recently been utilized in the management of
secondary meningiomas in isolation or following SRS for the
prevention of recurrences with a reasonable success [36,37], but
its possible future use in strictly intraosseous variants like ours
still needs to be assessed.
4. Conclusion
Clear cell meningioma may present as a purely intraosseous
osteolytic tumor 36 years after high dose cranial irradiation.
Immunohistochemistry plays a major role in the deﬁnitive
diagnosis to exclude other neoplasms with clear-cell features
and a multimodal management protocol taking beneﬁt from
the expansion of the available therapeutic armamentarium
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the prognosis depends on the time at diagnosis, a close follow
up extending over a long period of time should be indicated in
all previously irradiated patients.
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